| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Psychosomatic Medicine, Vol 59, Issue 4 362-371, Copyright © 1997 by American Psychosomatic Society
ORIGINAL ARTICLES |
CE Schwartz, MA Chesney, MJ Irvine and FJ Keefe
Behavorial Science Research Program, Frontier Science & Technology Research Foundation, Inc., Brookline, Massachusetts 02167-2104, USA. schwartz@jimmy.harvard.edu
OBJECTIVE: Clinical research on psychosocial and behavioral medicine interventions has burgeoned in the past two decades, so much so that sole reliance on standard no-treatment control conditions may no longer be appropriate or feasible. We discuss the ethical, theoretical, scientific, and statistical considerations that shape current clinical outcomes research for psychosocial and behavioral medicine interventions. METHOD AND RESULTS: Secondary analysis of a psychosocial randomized trial (N = 127) illustrates some of these points. CONCLUSIONS: A new design for randomized clinical trials is described that does not require a no-treatment control group, and that reveals dose-response relationships between interventions and treatment outcomes.
This article has been cited by other articles:
![]() |
D. Drotar and T. Palermo Commentary: Conducting Randomized Controlled Trials of Psychological Treatment to Improve the Outcomes of Recurrent Abdominal Pain: Contributions and Challenges J. Pediatr. Psychol., July 1, 2005; 30(5): 449 - 452. [Full Text] [PDF] |
||||
![]() |
D. Drotar Commentary: Randomized Controlled Trials of Psychological Interventions with Pediatric Populations: The Time has Come and the Journal of Pediatric Psychology is Ready J. Pediatr. Psychol., July 1, 2005; 30(5): 409 - 412. [Full Text] [PDF] |
||||
![]() |
V. H. Barkauskas, S. L. Lusk, and B. L. Eakin Selecting Control Interventions for Clinical Outcome Studies West J Nurs Res, April 1, 2005; 27(3): 346 - 363. [Abstract] [PDF] |
||||
![]() |
L. H. Kushi, J. E. Cunningham, J. R. Hebert, R. H. Lerman, E. V. Bandera, and J. Teas The Macrobiotic Diet in Cancer J. Nutr., November 1, 2001; 131(11): 3056S - 3064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Mohr, D. E. Goodkin, J. Islar, S. L. Hauser, and C. P. Genain Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis Arch Neurol, July 1, 2001; 58(7): 1081 - 1086. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |